{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Negative+Control&page=18", "query": { "intervention": "Negative Control", "page": 18 }, "page_size": 10 }, "pagination": { "page": 18, "page_size": 10, "total_count": 1038, "total_pages": 104, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Negative+Control&page=19&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Negative+Control&page=17&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T09:07:19.564Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00513474", "title": "Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Myeloproliferative Disorders", "Graft Versus Host Disease", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms" ], "interventions": [ { "name": "busulfan", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cyclosporin-A", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "rasburicase", "type": "DRUG" }, { "name": "sirolimus", "type": "DRUG" }, { "name": "tacrolimus", "type": "DRUG" }, { "name": "allogeneic hematopoietic stem cell transplantation", "type": "PROCEDURE" }, { "name": "peripheral blood stem cell transplantation", "type": "PROCEDURE" }, { "name": "total-body irradiation", "type": "RADIATION" }, { "name": "fludarabine", "type": "DRUG" }, { "name": "allopurinol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 46, "start_date": "2008-01", "completion_date": "2013-02-12", "has_results": true, "last_update_posted_date": "2017-05-25", "last_synced_at": "2026-10-20T09:07:19.564Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00513474" }, { "nct_id": "NCT00624650", "title": "Hemodynamics and Extravascular Lung Water in Acute Lung Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Lung Injury" ], "interventions": [ { "name": "Diuresis (furosemide) part I", "type": "DRUG" }, { "name": "Fluid Bolus (crystalloid or albumin)", "type": "OTHER" }, { "name": "Vasopressors (Norepinephrine, Vasopressin, Phenylephrine, Epinephrine)", "type": "DRUG" }, { "name": "Dobutamine", "type": "DRUG" }, { "name": "Concentrate all drips and nutrition", "type": "OTHER" }, { "name": "Diuresis (furosemide) part II", "type": "DRUG" }, { "name": "Dialysis", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "Oregon Health and Science University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2008-02", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2019-09-10", "last_synced_at": "2026-10-20T09:07:19.564Z", "location_count": 3, "location_summary": "Clackamas, Oregon • Portland, Oregon", "locations": [ { "city": "Clackamas", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00624650" }, { "nct_id": "NCT03949296", "title": "Mindfulness Meditation in Treating Insomnia in Multiple Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Insomnia Chronic", "Multiple Sclerosis" ], "interventions": [ { "name": "Mindfulness Intervention", "type": "BEHAVIORAL" }, { "name": "Sleep Hygiene", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Griffin Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2017-12-11", "completion_date": "2019-12-16", "has_results": false, "last_update_posted_date": "2020-02-26", "last_synced_at": "2026-10-20T09:07:19.564Z", "location_count": 1, "location_summary": "Derby, Connecticut", "locations": [ { "city": "Derby", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03949296" }, { "nct_id": "NCT02657382", "title": "Mental Stress Ischemia: Biofeedback Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiovascular Disease", "Coronary Artery Disease" ], "interventions": [ { "name": "Heart Rate Variability (HRV) Biofeedback (BF)", "type": "BEHAVIORAL" }, { "name": "Mental Stress Protocol", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2015-09", "completion_date": "2020-06-24", "has_results": false, "last_update_posted_date": "2020-09-14", "last_synced_at": "2026-10-20T09:07:19.564Z", "location_count": 4, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02657382" }, { "nct_id": "NCT07656545", "title": "Early Intervention to Prevent Development of PTSD in Burn Survivors and Their Caregivers", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Posttraumatic Stress Disorder", "Burns", "Traumatic Injury", "Acute Stress Disorder", "Trauma and Stressor Related Disorders", "Trauma and Stress Related Disorders", "Stress Disorder", "Stress Disorders, Post-Traumatic", "Stress Disorders, Traumatic", "Stress Disorders, Traumatic, Acute", "Relationship, Social" ], "interventions": [ { "name": "Promotion of Emotional Disclosure for Burns (PoED-B)", "type": "BEHAVIORAL" }, { "name": "minimally Enhanced Usual Care control (mEUC)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2026-08-01", "completion_date": "2029-02-28", "has_results": false, "last_update_posted_date": "2026-06-18", "last_synced_at": "2026-10-20T09:07:19.564Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07656545" }, { "nct_id": "NCT07318792", "title": "Using TropoCells(R) Autologous Platelet-Rich Fibrin (PRF) to Treat Chronic Non-Healing Wounds", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Wound Chronic Draining", "Wound Closure" ], "interventions": [ { "name": "Platelet-rich fibrin (PRF)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Estar Medical dba Medical Technologies, LTD", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 16, "start_date": "2026-01-01", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-01-06", "last_synced_at": "2026-10-20T09:07:19.564Z", "location_count": 3, "location_summary": "Bradenton, Florida • San Antonio, Texas", "locations": [ { "city": "Bradenton", "state": "Florida" }, { "city": "San Antonio", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07318792" }, { "nct_id": "NCT05683223", "title": "Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Social Anxiety Disorder" ], "interventions": [ { "name": "Group CBT for Social Anxiety Disorder", "type": "BEHAVIORAL" }, { "name": "Sertraline", "type": "DRUG" }, { "name": "Individual CBT for Social Anxiety Disorder", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "Boston University Charles River Campus", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 240, "start_date": "2023-05-26", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-10-20T09:07:19.564Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05683223" }, { "nct_id": "NCT06354270", "title": "A Clinical Study to Evaluate the Anti-Sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dentin Sensitivity" ], "interventions": [ { "name": "Stannous fluoride toothpaste", "type": "DRUG" }, { "name": "Regular fluoride toothpaste (Crest Cavity Protection)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "HALEON", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 115, "start_date": "2024-04-11", "completion_date": "2024-06-23", "has_results": true, "last_update_posted_date": "2025-06-25", "last_synced_at": "2026-10-20T09:07:19.564Z", "location_count": 1, "location_summary": "Melbourne, Florida", "locations": [ { "city": "Melbourne", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06354270" }, { "nct_id": "NCT06283173", "title": "HRIPT for Collagen Dressing", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Skin Sensitisation" ], "interventions": [ { "name": "ColActive Plus Collagen Matrix Dressing", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Covalon Technologies Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 86, "start_date": "2024-01-31", "completion_date": "2024-03-22", "has_results": true, "last_update_posted_date": "2025-03-12", "last_synced_at": "2026-10-20T09:07:19.564Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06283173" }, { "nct_id": "NCT00546403", "title": "Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Modafinil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Veterans Medical Research Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "18 Years to 65 Years · Male only" }, "enrollment_count": 26, "start_date": "2003-02", "completion_date": "2008-02", "has_results": false, "last_update_posted_date": "2009-02-24", "last_synced_at": "2026-10-20T09:07:19.564Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00546403" } ] }